A biomarker panel can improve prediction of chronic kidney disease progression in children aged 6 months to 16 years.

Mineralys Therapeutics announced positive topline results from its phase 2 Explore-CKD trial, in which lorundrostat lowered ...

As a result, a better assessment of renal function and dosage adjustment of drugs eliminated by the kidneys is needed in obese patients. The GFR is considered to be the best indicator of the ...

However, although Musk is as it appears, all-clear on the drug use, some social media users have expressed concern after spotting another detail in the results. People have pointed out that his ...

A 69-year-old man with type 2 diabetes, hypertension and stage 3 chronic kidney disease (CKD), hyperphosphataemia and borderline hyperkalaemia presented to an office visit interested in changing his ...

A simple, sensitive, and specific liquid chromatography−tandem mass spectrometry (LC−MS/MS) method for determining urinary creatinine was developed and used to evaluate 24 h urine samples collected ...

At day 180, the reduction in the urinary albumin-to-creatinine ratio with combination therapy was 29% greater than that with finerenone alone (least-squares mean ratio of the difference in the ...